Literature DB >> 10973160

Clinical and laboratory parameters in dapsone acute intoxication.

M Z Carrazza1, F R Carrazza, S Oga.   

Abstract

OBJECTIVE: To determine the severity of dapsone (DDS) acute intoxication - an uncommon medical event - using clinical and laboratory parameters.
METHODS: Two hundred and seventy four patients with acute DDS intoxication, aged 1 month to 50 years old, were studied and classified into four age groups. Clinical evaluation was assessed through a protocol and correlated with laboratory parameters. Spectrophotometric methods were used to analyze methemoglobinemia (MHbp) and dapsonemia (DDSp).
RESULTS: The most prevalent clinical sign of intoxication was cyanosis, seen in 65.7% of the patients and in 100% of children less than 5 years of age. According to laboratory criteria, MHbp-related severe clinical intoxication was seen in 56.2% and DDSp-related occurred in 58% of the patients. Regarding DDSp, intoxication was considered severe when 20 tablets (100 mg each) were ingested, a median of 29 microg/ml. Regarding MHbp, intoxication was severe when 7.5 tablets were ingested, a median of 38% of the total Hb. The correlation between MHbp and DDSp was statistically significant (n=144, r=0.32, p<0.05). Negative correlation was observed between MHbp and the time elapsed since DDS intake (n=124, r=-0.34, p<0.001). There was also a negative correlation between DDSp and the time elapsed since DDS intake (n=63, r=-0.35, p<0.0001).
CONCLUSIONS: Longitudinal analysis showed a significant association between methemoglobinemia and the time elapsed after the intake (t), according to the equation: Dapsonemia = 12.9256 - 0.0682t + 0.234 methemoglobinemia

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973160     DOI: 10.1590/s0034-89102000000400013

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  5 in total

Review 1.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.

Authors:  Carine Van Malderen; Jean-Pierre Van Geertruyden; Sonia Machevo; Raquel González; Quique Bassat; Ambrose Talisuna; Adoke Yeka; Carolyn Nabasumba; Patrice Piola; Atwine Daniel; Eleanor Turyakira; Pascale Forret; Chantal Van Overmeir; Harry van Loen; Annie Robert; Umberto D' Alessandro
Journal:  Malar J       Date:  2012-07-10       Impact factor: 2.979

Review 3.  Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review.

Authors:  Oluwaseun Egunsola; Kazeem A Oshikoya
Journal:  Malar J       Date:  2013-11-01       Impact factor: 2.979

4.  Clinical outcomes and kinetics of propanil following acute self-poisoning: a prospective case series.

Authors:  Darren M Roberts; Renate Heilmair; Nick A Buckley; Andrew H Dawson; Mohamed Fahim; Michael Eddleston; Peter Eyer
Journal:  BMC Clin Pharmacol       Date:  2009-02-16

5.  Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.

Authors:  Taysa Ribeiro Schalcher; Rosivaldo S Borges; Michael D Coleman; João Batista Júnior; Claudio G Salgado; Jose Luiz F Vieira; Pedro R T Romão; Fabio R Oliveira; Marta Chagas Monteiro
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.